Heinz Läubli

8.6k citations
95 papers · 4.9k indexed · 1 hit paper · h-index 38
Topics
Immunotherapy and Immune Responses (31 papers)Glycosylation and Glycoproteins Research (29 papers)Cancer Immunotherapy and Biomarkers (29 papers)

In The Last Decade

Heinz Läubli

85 papers receiving 4.8k citations

Hit Papers

Targeted glycan degradation potentiates the anticancer im...2020202620222024202050100150200

Peers

Heinz Läubli
Comparison fields: 5 of 124
  • Molecular Biology 2.6k
  • Immunology 2.1k
  • Oncology 1.8k
  • Pulmonary and Respiratory Medicine 479
  • Cancer Research 442
Replace Yasuhiko Nishioka with:
Yasuhiko Nishioka Japan
Belinda S. Parker Australia
Takuya Osada United States
Sophia N. Karagiannis United Kingdom
James N. Arnold United Kingdom
Bharat Joshi United States
Elaine M. Hurt United States
Mirco Ponzoni Italy
El–Nasir Lalani United Kingdom
Serge Jothy Canada
Heinz Läubli relative to Yasuhiko Nishioka Japan Yasuhiko Nishioka's profile →
Citations per field
00.5×4.0×
Yasuhiko Nishioka · 1×
Citations per year

Countries citing papers authored by Heinz Läubli

Since Specialization
Citations

This map shows the geographic impact of Heinz Läubli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heinz Läubli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heinz Läubli more than expected).

Fields of papers citing papers by Heinz Läubli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heinz Läubli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heinz Läubli. The network helps show where Heinz Läubli may publish in the future.

Co-authorship network of co-authors of Heinz Läubli

This figure shows the co-authorship network connecting the top 25 collaborators of Heinz Läubli. A scholar is included among the top collaborators of Heinz Läubli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heinz Läubli. Heinz Läubli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 7
3 2
4 7
5 0
6 25
7 60
8 49
9 47
10 11
11 1
12 1
13 36
14 58
15 12
16 22
17 0
18 50
19 41
20 110

About Heinz Läubli

Heinz Läubli is a scholar working on Immunology, Oncology and Immunology and Allergy, having authored 95 papers that have together received 4.9k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (31 papers), Glycosylation and Glycoproteins Research (29 papers) and Cancer Immunotherapy and Biomarkers (29 papers). The work is most often cited by research in Immunology (2.1k citations), Oncology (1.8k citations) and Immunology and Allergy (257 citations). Heinz Läubli has collaborated with scholars based in Switzerland, United States and United Kingdom. Frequent co-authors include Lubor Borsig, Oliver M.T. Pearce, Alfred Zippelius, Ajit Varki, Michal A. Stanczak, Nissi Varki, Annie N. Samraj, Natália Rodrigues Mantuano, Patrick Secrest and Otmar Pfister. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Angewandte Chemie International Edition.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026